WOLVERINE ASSET MANAGEMENT LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$3,777
-5.6%
1000.0%0.00%
Q3 2022$4,000
-95.6%
100
-96.7%
0.00%
-100.0%
Q4 2021$91,000
-9.0%
3,0000.0%0.00%0.0%
Q3 2021$100,000
-33.3%
3,000
-20.7%
0.00%0.0%
Q2 2021$150,000
+11.9%
3,783
+26.1%
0.00%0.0%
Q1 2021$134,000
-50.6%
3,000
-37.5%
0.00%
-50.0%
Q4 2020$271,000
+19.4%
4,8000.0%0.00%0.0%
Q3 2020$227,000
-59.5%
4,800
-49.6%
0.00%
-66.7%
Q2 2020$560,000
+558.8%
9,532
+429.6%
0.01%
+500.0%
Q1 2020$85,000
-47.5%
1,800
-33.3%
0.00%
-50.0%
Q4 2019$162,000
-70.6%
2,700
-60.3%
0.00%
-75.0%
Q1 2019$551,000
-11.3%
6,800
-51.8%
0.01%0.0%
Q1 2018$621,000
-75.0%
14,100
-71.5%
0.01%
-68.0%
Q4 2017$2,484,000
-28.1%
49,400
-27.6%
0.02%
-34.2%
Q3 2017$3,457,000
-34.4%
68,200
-34.2%
0.04%
-43.3%
Q2 2017$5,269,000
+4.0%
103,600
-17.8%
0.07%
-15.2%
Q1 2017$5,065,000
-62.2%
126,000
-55.1%
0.08%
-54.3%
Q4 2016$13,412,000
+227.4%
280,442
+150.8%
0.17%
+183.6%
Q3 2016$4,096,000
+51.8%
111,800
-3.5%
0.06%
+48.8%
Q2 2016$2,699,000
+2076.6%
115,900
+42825.9%
0.04%
+925.0%
Q1 2016$124,000
+153.1%
270
-50.1%
0.00%
+300.0%
Q4 2015$49,0005410.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders